NO20023678L - Behandling av allergiske og inflammatoriske tilstander - Google Patents
Behandling av allergiske og inflammatoriske tilstanderInfo
- Publication number
- NO20023678L NO20023678L NO20023678A NO20023678A NO20023678L NO 20023678 L NO20023678 L NO 20023678L NO 20023678 A NO20023678 A NO 20023678A NO 20023678 A NO20023678 A NO 20023678A NO 20023678 L NO20023678 L NO 20023678L
- Authority
- NO
- Norway
- Prior art keywords
- allergic
- treatment
- inflammatory conditions
- inflammatory
- conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18009100P | 2000-02-03 | 2000-02-03 | |
| PCT/US2001/003252 WO2001056571A1 (en) | 2000-02-03 | 2001-02-01 | Treating allergic and inflammatory conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20023678D0 NO20023678D0 (no) | 2002-08-02 |
| NO20023678L true NO20023678L (no) | 2002-08-02 |
Family
ID=22659164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20023678A NO20023678L (no) | 2000-02-03 | 2002-08-02 | Behandling av allergiske og inflammatoriske tilstander |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6432972B2 (no) |
| EP (1) | EP1251851A1 (no) |
| JP (1) | JP2003521515A (no) |
| CN (1) | CN1213752C (no) |
| AR (1) | AR028502A1 (no) |
| AU (1) | AU3800601A (no) |
| BR (1) | BR0107960A (no) |
| CA (1) | CA2398261A1 (no) |
| HK (1) | HK1046367A1 (no) |
| HU (1) | HUP0204048A3 (no) |
| MX (1) | MXPA02007558A (no) |
| MY (1) | MY122838A (no) |
| NO (1) | NO20023678L (no) |
| NZ (1) | NZ519797A (no) |
| WO (1) | WO2001056571A1 (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001021161A2 (en) * | 1999-09-21 | 2001-03-29 | Schering Corporation | Use of desloratadine for treating allergic and inflammatory conditions |
| SK287105B6 (sk) | 1999-12-20 | 2009-12-07 | Schering Corporation | Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním |
| SK287684B6 (sk) * | 1999-12-20 | 2011-06-06 | Schering Corporation | Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním |
| US7405223B2 (en) * | 2000-02-03 | 2008-07-29 | Schering Corporation | Treating allergic and inflammatory conditions |
| US6651816B2 (en) | 2001-05-04 | 2003-11-25 | Robert E. Weinstein | Antihistamine/decongestant regimens for treating rhinitis |
| WO2003000264A1 (en) * | 2001-06-20 | 2003-01-03 | Schering Corporation | Antihistamines for the treatment of nasal congestion and nasal obstruction |
| US20030236275A1 (en) * | 2002-06-20 | 2003-12-25 | Schering Corporation | Treatment methods of nasal congestion and nasal obstruction |
| US6599913B1 (en) * | 2001-06-29 | 2003-07-29 | Schering Corporation | Treating allergic and inflammatory conditions |
| JP4303925B2 (ja) * | 2002-08-19 | 2009-07-29 | 篠田プラズマ株式会社 | 金属酸化膜の形成方法及びガス放電管の２次電子放出膜形成方法 |
| WO2006017505A2 (en) * | 2004-08-04 | 2006-02-16 | Schering Corporation | Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases |
| US8815890B2 (en) * | 2006-09-06 | 2014-08-26 | Robert E. Weinstein | Rhinitis treatment regimens |
| US20090082385A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched desloratidine |
| WO2010147947A2 (en) | 2009-06-16 | 2010-12-23 | Schering Corporation | NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU570306B2 (en) * | 1984-02-15 | 1988-03-10 | Schering Corporation | 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridine and its salts. |
| US5595997A (en) * | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| AU722040B2 (en) * | 1996-08-16 | 2000-07-20 | Schering Corporation | Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
| US5900421A (en) * | 1997-02-11 | 1999-05-04 | Sepracor Inc. | Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine |
| CN1283115A (zh) * | 1997-12-23 | 2001-02-07 | 先灵公司 | 用于治疗呼吸道和皮肤病的含有至少一种白三烯拮抗剂和至少一种抗组胺药的组合物 |
| US6114346A (en) * | 1999-10-22 | 2000-09-05 | Schering Corporation | Treating sleep disorders using desloratadine |
-
2001
- 2001-02-01 BR BR0107960-3A patent/BR0107960A/pt not_active IP Right Cessation
- 2001-02-01 EP EP01910395A patent/EP1251851A1/en not_active Withdrawn
- 2001-02-01 JP JP2001556470A patent/JP2003521515A/ja not_active Withdrawn
- 2001-02-01 MX MXPA02007558A patent/MXPA02007558A/es active IP Right Grant
- 2001-02-01 CA CA002398261A patent/CA2398261A1/en not_active Abandoned
- 2001-02-01 HU HU0204048A patent/HUP0204048A3/hu unknown
- 2001-02-01 AR ARP010100480A patent/AR028502A1/es unknown
- 2001-02-01 AU AU38006/01A patent/AU3800601A/en not_active Abandoned
- 2001-02-01 CN CNB018043593A patent/CN1213752C/zh not_active Expired - Fee Related
- 2001-02-01 NZ NZ519797A patent/NZ519797A/en unknown
- 2001-02-01 WO PCT/US2001/003252 patent/WO2001056571A1/en active IP Right Grant
- 2001-02-02 MY MYPI20010475A patent/MY122838A/en unknown
- 2001-02-05 US US09/777,109 patent/US6432972B2/en not_active Expired - Fee Related
-
2002
- 2002-08-02 NO NO20023678A patent/NO20023678L/no unknown
- 2002-10-31 HK HK02107906.6A patent/HK1046367A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6432972B2 (en) | 2002-08-13 |
| EP1251851A1 (en) | 2002-10-30 |
| AU3800601A (en) | 2001-08-14 |
| CN1404391A (zh) | 2003-03-19 |
| WO2001056571A1 (en) | 2001-08-09 |
| NZ519797A (en) | 2005-05-27 |
| AR028502A1 (es) | 2003-05-14 |
| NO20023678D0 (no) | 2002-08-02 |
| HUP0204048A2 (hu) | 2003-03-28 |
| CA2398261A1 (en) | 2001-08-09 |
| HK1046367A1 (zh) | 2003-01-10 |
| US20010039282A1 (en) | 2001-11-08 |
| MY122838A (en) | 2006-05-31 |
| BR0107960A (pt) | 2002-10-29 |
| JP2003521515A (ja) | 2003-07-15 |
| HUP0204048A3 (en) | 2004-07-28 |
| MXPA02007558A (es) | 2002-12-13 |
| CN1213752C (zh) | 2005-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1489915A4 (en) | TREATMENT AND PREVENTION OF INFLAMMATORY DISORDERS | |
| NO20041582L (no) | Antistoffinhibitorer av GDF-8 og anvendelse derav | |
| NO20015773D0 (no) | Forhindring og behandling av amyloidogen sykdom | |
| ATE410421T1 (de) | P38 inhibitor und anwendungsverfahren dafür | |
| DE60317799D1 (de) | Antimikrobielle zusammensetzung und anwendungsverfahren | |
| AU2002352726A8 (en) | Formulations and methods for treatment or amelioration of inflammatory conditions | |
| IS7907A (is) | Astmi og stillar ofnæmisbólgu | |
| NO20030725D0 (no) | Terapeutisk kombinasjon av CETP-inhibitor og atorvastatin | |
| EP1412378A4 (en) | APTAMERES AND ANTIAPTAMERS | |
| NO20030148L (no) | Rengjöring og smöring av rör | |
| EP1423399A4 (en) | HYDROXYPYRIDONATE AND HYDROXYPYRIMIDINONE CHELATIZING AGENTS | |
| NO20030397L (no) | Amyloid målsökende billeddannende midler og anvendelser av samme | |
| DK1392292T3 (da) | Pyranoindazoler og deres anvendelse til behandling af glaukom | |
| NO20023678D0 (no) | Behandling av allergiske og inflammatoriske tilstander | |
| IS6966A (is) | Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
| IS2867B (is) | Neublastín sem tengt er fjölliðu og aðferðir við notkun þess | |
| IS6967A (is) | Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
| DK1341786T3 (da) | Substituerede derivater af aminofuran-2-yl-eddikesyre og aminothien-2-yl-eddikesyre og anvendelsen deraf til behandling af migræner og smerte | |
| AU2001233259A1 (en) | Use of desloratadine for treating allergic and inflammatory conditions | |
| NO20030978L (no) | Behandling av urindysfunksjon | |
| NO20024236D0 (no) | Behandling av psoriasis | |
| NO20020326L (no) | Sammensetning og anvendelse av en inhibitor av PPAR-delta-aktivitet | |
| DE60139740D1 (de) | Verzögerungsschaltung und Vorwärtskopplungsverstärker | |
| EE200300570A (et) | Imidasotriasinoonide derivaadid ja nende kasutamine põletikuliste protsesside ja/või immuunhaigustevastu | |
| DK1381620T3 (da) | Hypersulfaterede disaccharider og fremgangsmåder til anvendelse af samme til behandling af inflammationer |